Table 2.

Physician-reported likelihood of SLE pretest and post-test

	Pretest; enrolment	Post-test; review of test results	Post-test;12 weeks
SDLT arm n=73	1.42±0.06	1.23±0.08 (−0.19±0.07)	1.11±0.10 (−0.31±0.10)
MAP/CB-CAPs testing arm n=72	1.46±0.06	1.01±0.10 (−0.44±0.10)	0.85±0.10 (−0.61±0.10)

Results are expressed as mean (SEM) at each study visit and as change from enrolment (in parenthesis).

CB-CAPs, cell-bound complement activation products; MAP, multianalyte assay panel; SDLT, standard diagnosis laboratory testing.